Sanofi Collaboration Technology definition

Sanofi Collaboration Technology means all Inventions and Know-How discovered, conceived, or created, solely [***] and in whose Inventions and Know-How Sanofi otherwise has ownership rights, in each case as a result of the performance of [***] as well as any and all Patents arising from the same.
View Source
Sanofi Collaboration Technology means the Collaboration Technology solely owned by Sanofi in accordance with Sections 10.2, 10.4 or 10.5.
View Source
Sanofi Collaboration Technology has the meaning set forth in Section 1.217 (Sanofi Technology).
View Source

Examples of Sanofi Collaboration Technology in a sentence

  • Sanofi will have the right, at its sole discretion, to file, prosecute, defend and maintain at its costs any Patents claiming Inventions or Know-How included in the Sanofi Collaboration Technology.

  • Sanofi will keep Selecta reasonably apprised with respect to the filing, prosecution and maintenance of such Patents within the Sanofi Collaboration Technology.

  • Subject to the licenses and rights granted to Selecta pursuant to this Agreement, the entire right, title and interest in and to all Sanofi Collaboration Technology shall be owned solely and exclusively by Sanofi.

  • Without limiting the foregoing, Selecta Collaboration Technology and Selecta Licensed Technology (other than Joint Collaboration Technology) will be considered Confidential Information of Selecta, and Sanofi Collaboration Technology will be considered Confidential Information of Sanofi.

  • Sanofi retains all right and title in and to all of the Sanofi Background Technology, Sanofi Collaboration Technology (including the Sanofi Reserved Property) and Sanofi Improvements not expressly granted to Translate Bio hereunder.

  • Any determination of inventorship with respect to any Sanofi Collaboration Technology, Selecta Collaboration Technology, and Joint Collaboration Technology (and thus potentially ownership under this Section 8) shall be made in accordance with applicable United States patent laws.

  • In consideration of the license granted by Sanofi to Translate Bio under this Section 9.6.1 Translate Bio agrees to pay Sanofi a royalty of [**] percent ([**]%) on Translate Bio’s Sublicensees’ Net Sales, mutatis mutandis, in respect of any product in the Translate Bio Field in the Territory that is covered by a Valid Patent Claim, mutatis mutandis, of a Patent claiming Sanofi Collaboration Technology.